Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases

Journal of Nuclear Medicine

Volumn 38, Issue 3, 1997, Pages 386-390

  Sahu, Shailendra K ^a   Wen, Patrick Y C ^a   Foulon, Catherine F ^a   Nagel, James S ^a   Black, Peter McL ^a   Adelstein, S James ^a   Kassis, Amin I ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Shields Warren Radiation Laboratory   (United States)

Author keywords

Gliosarcoma; Intrathecal tumor; Iodine 125 IUdR; Leptomeningeal metastases

Indexed keywords

IDOXURIDINE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CARCINOMATOUS MENINGITIS; CLINICAL FEATURE; GLIOSARCOMA; INTRATHECAL DRUG ADMINISTRATION; MALE; METASTASIS INHIBITION; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RAT; ANIMAL; AREA UNDER THE CURVE; FISCHER 344 RAT; INTRASPINAL DRUG ADMINISTRATION; MENINGIOMA; METASTASIS; PATHOLOGY; RADIOGRAPHY; SPINAL CORD;

ANIMALS; AREA UNDER CURVE; AUTORADIOGRAPHY; GLIOSARCOMA; IDOXURIDINE; INJECTIONS, SPINAL; IODINE RADIOISOTOPES; MALE; MENINGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; PARALYSIS; RATS; RATS, INBRED F344; SPINAL CORD;

EID: 0030615050     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Grossman SA, Moynihan TJ. Neoplastic meningitis. Neurol Clin 1991;9:843-856.
2. Wen PYC, Fine HA. Leptomeningeal metastases. In: Black PMcL, Loeffler SS, eds. Cancer in the nervous system. Cambridge, MA: Blackwell Science Inc. 1997:288-309.
3. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759-772.
4. 125I. Radiat Res 1981;87:10-23.
5. 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiat Res 1987;109:78-89.
6. 3H. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Int J Radiat Biol 1975;28:225-241.
7. Kassis AI, Howell RW, Sastry KSR, Adelstein SJ. Positional effects of Auger decays in mammalian cells in culture. In: Baverstock KF, Charlton DE, eds. DNA damage by Auger emitters. London: Taylor and Francis; 1988:1-13.
8. 125I-labeled DNA intercalator in mammalian cells. Radiat Res 1989;118:283-294.
9. Calabresi P, Cardoso SS, Finch SC, et al. Initial clinical studies with 5-iodo-2′-deoxyuridine. Cancer Res 1961;21:550-559.
10. Prusoff WH. A review of some aspects of 5-iododeoxyundine and azauridine. Cancer Res 1963;23:1246-1259.
11. Lee DJ, Prensky W, Krause G, Hughes WL. Blood thymidine level and iododeoxyuridine incorporation and reutilization in DNA in mice given long-acting thymidine pellets. Cancer Res 1976;36:4577-4583.
12. Klecker RW Jr, Jenkins JF, Kinsella TJ, Fine RL, Strong JM, Collins JM. Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin Pharmacol Ther 1985;38:45-51.
13. 125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature 1977;265:620-621.
14. 123I]iodo-2′-deoxyuridine in the radiotherapy of an early ascites tumor model. Int J Radiat Oncol Biol Phys 1991;21:1541-1551.
15. Kassis AI, Van den Abbeele AD, Wen PYC, et al. 5-[I-125]iodo-2′-deoxyuridine in the radiotherapy of solid brain tumors in rats [Abstract]. J Nucl Med 1993;34(suppl):241P-242P.
16. Kooistra KL, Rodriguez M, Powis G, et al. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res 1986;46:317-323.
17. Schmidek HH, Nielsen SL, Schiller AL, Messer J. Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J Neurosurg 1971;34:335-340.
18. Foulon CF, Zhang YZ, Adelstein SJ, Kassis AI. Instantaneous preparation of radiolabeled 5-iodo-2′-deoxyuridine. Appl Radiat Isot 1995;46:1039-1046.
19. Lashford L, Moseley RP, Benjamin JC, et al. Antibody targeted irradiation for leptomeningeal neoplasia: current status. J Neurooncol 1989;7:S17.
20. Ram Z, Walbridge S, Oshiro EM, et al. Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res 1994;54:2141-2145.
21. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS. for the Eastern Cooperative Oncology Group. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993;11:561-569.
22. Berg SL, Balis FM, Zimm S, et al. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies. J Clin Oncol 1992;10:143-148.
23. Friedman HS, Archer GE, McLendon RE, et al. Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats. Cancer Res 1994;54:5118-5122.
24. 125I-labeled DNA-binding compound that induces double-stranded DNA breaks. Cancer Res 1979;39:3244-3247.
25. Schmidt A, Hotz G. The occurrence of doubles-strand breaks in coliphage T1-DNA by iodine-125 decay. Int J Radiat Biol 1973;24:307-313.
26. 4. Int J Radiat Biol 1974;25:21-30.
27. 125I decay in microorganisms. Curr Top Radiat Res Q 1978;12:355-368.
28. Linz U, Stöcklin G. Chemical and biological consequences of the radioactive decay of iodine-125 in plasmid DNA. Radial Res 1985;101:262-278.
29. Krisch RE, Flick MB, Trumbore CN. Radiation chemical mechanisms of single- and double-strand break formation in irradiated SV40 DNA. Radiat Res 1991;126:251-259.
30. Makrigiorgos GM, Berman RM, Baranowska-Kortylewicz J, et al. DNA damage produced in V79 cells by DNA-incorporated iodine-123: a comparison with iodine-125. Radiat Res 1992;129:309-314.
31. 1-phase CHO-cells. Int J Radiat Biol 1987;52:705-722.
32. Warters RL, Hofer KG, Harris CR, Smith JM. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site of radiation damage. Curr Top Radiat Res Q 1977;12:389-407.
33. 125I in mammalian cells. Radial Res 1987;111:305-318.
34. Kassis AI, Makrigiorgos GM, Adelstein SJ. Dosimetric considerations and therapeutic potential of Auger electron emitters. In: Adelstein SJ, Kassis AI, Burt RW, eds. Frontiers in nuclear medicine: dosimetry of administered radionuclides, proceedings of symposium, Washington, DC, 1989. Washington, DC: American College of Nuclear Physicians; 1990:257-274.
35. 125I]iodo-2′-deoxyuridine in mammalian cells following treatment with 5-fluoro-2′-deoxyuridine. J Nucl Biol Med 1991;35:167-173.
36. 125I]iodo-2′-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 1990;50:5199-5203.